Dae Sung Park

Dae Sung Park

Auto-generated profile, based on publicly available information

Dae Sung Park

The Korea Cardiovascular Stent Research Institute, Chonnam National University, Gwangju, Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
DJDa-Won Jeong
Da-Won Jeong
Wooram ParkWooram Park
Wooram Park
TBTarek Mosaid Bedair
Tarek Mosaid Bedair
EKEun Young Kang
Eun Young Kang
Ik-Hwan KimIk-Hwan Kim
Ik-Hwan Kim
Dong Keun HanDong Keun Han
Dong Keun Han
Drug-eluting stents (DESs) have been widely used as a treatment approach for coronary artery diseases. Generally, conventional DESs were fully covered with drugs and biodegradable polymers on both abluminal and luminal layers (i.e., conformal coating). However, uncontrolled drug release from the luminal drug-coating layer of the stent is known to inhibit re-endothelialization. Furthermore, the acidification of the surrounding tissue by the decomposed coating polymer causes inflammation, resulting in restenosis and late thrombosis. To overcome these limitations, here we demonstrated a functional DES coated with poly(lactic-co-glycolic acid) (PLGA), sirolimus (SRL), and magnesium hydroxide (Mg(OH)2, MH) precisely only on the abluminal layer. The acidic neutralization effect of MH was elucidated by measuring the pH change of the fabricated film in PBS solution. In an in vitro cell study, the stent coated with MH exhibited higher compatibility with human coronary artery endothelial cells (ECs) and a lower inflammation score as compared to the control stent. Finally, in an in vivo large porcine model, the abluminal coated DES with SRL and MH showed excellent re-endothelialization and anti-inflammatory and anti-thrombotic effects. In conclusion, it is believed that this approach has great potential for the development of functional DES for the treatment of cardiovascular diseases.

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DSDoo Sun Sim
Doo Sun Sim
MJMyung Ho Jeong
Myung Ho Jeong
HSHo Chun Song
Ho Chun Song
JKJahae Kim
Jahae Kim
ACAri Chong
Ari Chong
JKJung Chaee Kang
Jung Chaee Kang
Sim DS, et al. J Korean Med Sci. 2015 Jan;30(1):34-43. https://doi.org/10.3346/jkms.2015.30.1.34

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KCKyung Hoon Cho
Kyung Hoon Cho
MJMyung Ho Jeong
Myung Ho Jeong
DPDae Sung Park
Dae Sung Park
MKMoonki Kim
Moonki Kim
JKJungHa Kim
JungHa Kim
YAYoungkeun Ahn
Youngkeun Ahn
Cho KH, et al. J Korean Med Sci. 2021 Sep;36(40):e259. https://doi.org/10.3346/jkms.2021.36.e259

4 June 2024 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
DPDae Sung Park
Dae Sung Park
MNMi Hyang Na
Mi Hyang Na
MJMyung Ho Jeong
Myung Ho Jeong
DSDoo Sun Sim
Doo Sun Sim
YJYu Jeong Jin
Yu Jeong Jin
JKJeong Hun Kim
Jeong Hun Kim

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHyun Kuk Kim
Hyun Kuk Kim
HKHan Byul Kim
Han Byul Kim
JLJoo Myung Lee
Joo Myung Lee
SKSung Soo Kim
Sung Soo Kim
IBIn Ho Bae
In Ho Bae
MJMyung Ho Jeong
Myung Ho Jeong
Kim HK, et al. J Korean Med Sci. 2019 May;34(19):e145. https://doi.org/10.3346/jkms.2019.34.e145

16 November 2023 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
DPDae Sung Park
Dae Sung Park
SOSeok Oh
Seok Oh
YJYu Jeong Jin
Yu Jeong Jin
MNMi Hyang Na
Mi Hyang Na
MKMunki Kim
Munki Kim
MJMyung Ho Jeong
Myung Ho Jeong